Aztreonam .beta. polymorph with very low residual solvent content

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7452991
APP PUB NO 20050014739A1
SERIAL NO

10847123

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to the .beta. polymorph of Aztreonam, which contains less than 2.5% by weight residual solvent and to a process of making said polymorph. In the process of the invention, a polymorph of Aztreonam is dissolved in an absolute C.sub.1-6 alcohol in the presence of a base to form a solution, an acid is added to the solution, and the solution is stirred efficiently.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • TEVA PHARMACEUTICALS USA, INC.;BIOAL GYOGYSZERGYAR RT.;TEVA GYOGYSZERGYAR RESZVENYTARSASAG

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Amir, Ehud Ramat-Aviv, IL 22 133
Gyollai, Viktor Debrecen, HU 10 13
Singer, Claude Kfar Saba, IL 76 201
Szabo, Csaba Debrecen, HU 116 564

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation